Journal Home
Search for

Volume 5, Issue 1, Pages 15-19 (March 2003)


View previous. 6 of 13 View next.

The expression of a novel stress protein ‘150-kDa oxygen regulated protein’ in sudden infant death

Kazuya IkematsuaCorresponding Author Informationemail address, Ryouichi Tsudaa, Toshikazu Kondob, Hisayoshi Kondoc, Kentaro Ozawad, Satoshi Ogawad, Ichiro Nakasonoa

Received 14 May 2002; received in revised form 26 October 2002; accepted 28 October 2002.

Abstract 

The oxygen regulated protein 150-kDa (ORP-150) is only induced in hypoxic conditions. We performed an immunohistochemical and morphometrical study on the expression of ORP-150 in the brains of sudden infant death (SID) victims. The cerebral cortexes of 18 infants were used for this study. Each tissue section was incubated with anti-ORP-150 polyclonal antibodies and the number of ORP-150 positive cells was counted. In the cluster analysis, the 18 cases were classified into three groups (A–C groups). Group A was composed of six sudden infant death syndrome (SIDS) cases and its mean value of ORP-150 positive cells was 66.75±3.44, Group B (six severe respiratory infectious disease such as pneumonia and bronchitis including sepsis): 39.50±2.52 and Group C (five SIDS and one severe respiratory infectious disease): 16.00±2.92, respectively. These results might reflect chronic hypoxic condition before death, because ORP-150 is only induced when a hypoxic condition exist, but not acute hypoxia. And chronic hypoxic state is likely to be antecedent to SIDS. Therefore, immunohistochemical analysis of OPR-150 in the brain of SID cases may be very useful to differentiate between SIDS and acute asphyxia.

a Division of Forensic Pathology and Science, Department of Translational Medical Sciences, Course of Medical and Dental Sciences, Graduate School of Biochemical Sciences, Nagasaki University, Nagasaki City, Nagasaki 852-8523, Japan

b Department of Forensic and Social Environmental Medicine, Graduate School of Medical Science, Kanazawa University, 13-1 Takaramachi, Kanazawa City, Ishikawa 920-8640, Japan

c Atomic Bomb Disease Institute Division of Scientific Data Registry, Biostatics Section, Nagasaki University School of Medicine, Nagasaki City, Nagasaki 852-8523, Japan

d Department of Neuroanatomy, Kanazawa University Faculty of Medicine, 13-1 Takaramachi, Kanazawa City, Ishikawa 920-8640, Japan

Corresponding Author InformationCorresponding author. Tel.: +81-95-849-7076; fax: +81-95-849-7078

PII: S1344-6223(02)00072-X


View previous. 6 of 13 View next.